Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis-Reference-Cited by-同舟云学术

Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis

Published:2008-06 Issue:5 Volume:141 Page:745-747
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

de Lavallade Hugues,Punnialingam Sinthiya,Milojkovic Dragana,Bua Marco,Khorashad Jamshid S.,Gabriel Ian H.,Chaidos Aristeidis,Olavarria Eduardo,Goldman John M.,Apperley Jane F.,Marin David

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07108.x/fullpdf

Reference8 articles.

1. Hypersensitivity Pneumonitis Related to Imatinib Mesylate

2. Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia

3. Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

4. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

5. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An association between Dasatinib, elevated left atrial pressure and pleural effusion;International Journal of Cardiology;2024-09

2. A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database;Scientific Reports;2024-04-25

3. Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML;Annals of Hematology;2024-04-18

4. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP;Pleura and Peritoneum;2024-02-28

5. Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study;Leukemia;2023-11-25